MWA
INBX icon

Meridian Wealth Advisors’s Inhibrx INBX Stock Holding History

Meridian Wealth Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$706K Hold
10,500
– – 0.09% 116
2025
Q4 		$830K Sell
10,500
-14,500
-58% -$988K 0.11% 101
2025
Q3 		$842K Hold
25,000
– – 0.12% 100
2025
Q2 		$357K Hold
25,000
– – 0.06% 139
2025
Q1 		$350K Hold
25,000
– – 0.06% 135
2024
Q4 		$385K Buy
+25,000
New +$381K 0.06% 131

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Meridian Wealth Advisors's INBX Position: Q1 2026 in Review

Meridian Wealth Advisors held its Inhibrx (INBX) position steady in Q1 2026 at 10,500 shares worth $706K. The position accounts for 0.09% of the portfolio, ranked #116.

Meridian Wealth Advisors first reported a position in INBX in Q4 2024 and has held it in 6 quarters since. The position peaked at $842K in Q3 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Meridian Wealth Advisors held 10,500 shares of Inhibrx worth $706K as of Q1 2026.
  • Meridian Wealth Advisors left its Inhibrx share count unchanged in Q1 2026.
  • Inhibrx made up 0.09% of Meridian Wealth Advisors's portfolio in Q1 2026, its #116 holding.
  • Meridian Wealth Advisors first reported a position in Inhibrx in Q4 2024 and has held it in 6 quarters since.
  • Meridian Wealth Advisors's Inhibrx position peaked at $842K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Meridian Wealth Advisors's 13F filing for Q1 2026, filed 11 May 2026.